Cargando…

Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, disabling side effect in non-small cell lung cancer (NSCLC) patients treated with platinum-based therapy. There is increasing evidence for associations between genetic variants and susceptibility to CIPN. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jong, Corine, Herder, Gerarda J. M., van Haarlem, Simone W. A., van der Meer, Femke S., van Lindert, Anne S. R., ten Heuvel, Alexandra, Brouwer, Jan, Egberts, Toine C. G., Deneer, Vera H. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858836/ https://www.ncbi.nlm.nih.gov/pubmed/36672910 http://dx.doi.org/10.3390/genes14010170

Ejemplares similares

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients
por: de Jong, Corine, et al.
Publicado: (2022)

Association between serum biomarkers CEA and LDH and response in advanced non‐small cell lung cancer patients treated with platinum‐based chemotherapy
por: de Jong, Corine, et al.
Publicado: (2020)

Genetic variants as predictors of toxicity and response in patients with non‐small cell lung cancer undergoing first‐line platinum‐based chemotherapy: Design of the multicenter PGxLUNG study
por: de Jong, Corine, et al.
Publicado: (2020)

Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study
por: Zazuli, Zulfan, et al.
Publicado: (2021)

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

Insights into platinum-induced peripheral neuropathy–current perspective
por: Lazić, Andrijana, et al.
Publicado: (2020)

Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth
por: Cerles, Olivier, et al.
Publicado: (2019)

The Nature, Causes, and Clinical Impact of Errors in the Clinical Laboratory Testing Process Leading to Diagnostic Error: A Voluntary Incident Report Analysis
por: van Moll, Christel, et al.
Publicado: (2023)

Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020)

Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems
por: Hu, Xi, et al.
Publicado: (2021)

Efficacy of Mecobalamin Tablets Combined with Troxerutin in the Treatment of NSCLC Chemotherapy-Induced Peripheral Neuropathy
por: Li, Yang, et al.
Publicado: (2022)

The association between vincristine‐induced peripheral neuropathy and health‐related quality of life in children with cancer
por: van de Velde, Mirjam E., et al.
Publicado: (2021)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN)
por: Gadgil, Suvarna, et al.
Publicado: (2019)

Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients
por: van de Velde, Mirjam E., et al.
Publicado: (2022)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

Platinum type is key in determining degree of neuropathy
por: Muggia, Franco, et al.
Publicado: (2018)

Treatment emergent peripheral neuropathy in the CASSIOPEIA trial
por: Fokkema, Cathelijne, et al.
Publicado: (2022)

Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial)
por: van de Velde, Mirjam Esther, et al.
Publicado: (2020)

Intravenous Lidocaine: Old-School Drug, New Purpose—Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy
por: van den Heuvel, Sandra A. S., et al.
Publicado: (2017)

Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.
por: Screnci, D., et al.
Publicado: (1997)

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
por: Hilkens, P. H., et al.
Publicado: (1997)

Workshop on Perspectives on Radio Astronomy : Science with Large Antenna Arrays
por: Van Haarlem, M P
Publicado: (1999)

Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016)
por: Ueno, Takayoshi, et al.
Publicado: (2014)

Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy
por: Hung, Hsing-Wei, et al.
Publicado: (2021)

Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric–modified Total Neuropathy Score
por: Schouten, S. M., et al.
Publicado: (2019)

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
por: Rommers, Mirjam K, et al.
Publicado: (2006)

An Early Diagnostic Tool for Diabetic Peripheral Neuropathy in Rats
por: Kambiz, Shoista, et al.
Publicado: (2015)

Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey
por: Bekker, Charlotte, et al.
Publicado: (2019)

PERIPHERAL ENTRAPMENT NEUROPATHIES
Publicado: (1964)

Peripheral neuropathy in thalassemia
por: Sawaya, Raja A., et al.
Publicado: (2006)

Diagnosis of peripheral neuropathy
por: Lehmann, Helmar C., et al.
Publicado: (2020)

Orphan Peripheral Neuropathies
por: Finsterer, Josef, et al.
Publicado: (2021)

Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC
por: Peng, Wenpan, et al.
Publicado: (2021)

Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia
por: van Geijlswijk, Ingeborg M., et al.
Publicado: (2011)

Correction: An Early Diagnostic Tool for Diabetic Peripheral Neuropathy in Rats
por: Kambiz, Shoista, et al.
Publicado: (2015)

Recent Advances and Future Perspective of DC-Based Therapy in NSCLC
por: van der Hoorn, Iris A. E., et al.
Publicado: (2021)

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs
por: Uijtendaal, Esther V., et al.
Publicado: (2011)

Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia
por: Kavanagh, Simon, et al.
Publicado: (2018)

Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics
por: Minjon, Lenneke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mpb8ff03ahhbdhp1qiqg993s7q